Publisher Correction: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician

By sjmartinez • February 2, 2024

Szekanecz Z, Buch MH, Charles-Schoeman C, Galloway J, Karpouzas GA, Kristensen LE, Ytterberg SR, Hamar A, Fleischmann R. Publisher Correction: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nat Rev Rheumatol. 2024 Feb 1. doi: 10.1038/s41584-024-01085-w. Epub ahead of print. Erratum for: Nat Rev Rheumatol. 2024 Feb;20(2):101-115. PMID: 38302658.

Tags: Publications, Rheumatology

Delisted Patents on Pharmaceuticals, 1998-2024

Kirby-Rivera L, Feldman W, Kim M, Kosmopoulou G, Kesselheim AS, Tu SS. Delisted Patents on Pharmaceuticals, 1998-2024. J Law Med Ethics. 2026 Oct 2:1-4. doi:[...]

Psychosocial burden in cancer survivors

Ganz PA. Psychosocial burden in cancer survivors. Nat Rev Cancer. 2026 Oct 1. doi: 10.1038/s41568-026-00986-0. Epub ahead of print. PMID: 42823480.

Probable invasive Alternaria rhinosinusitis in a previously healthy patient diagnosed with heterozygous CARD9 deficiency and combined immunodeficiency

Luo J, Cushing TR, Bjella JD, Chung D, Saby AH. Refractory Thigh Pain Revealing Femoral Neuritis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Case Report. Cureus.[...]